Eversept Partners as of March 31, 2019
Portfolio Holdings for Eversept Partners
Eversept Partners holds 54 positions in its portfolio as reported in the March 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation (AMRN) | 12.6 | $43M | 2.1M | 20.76 | |
| GlaxoSmithKline | 10.1 | $34M | 803k | 42.41 | |
| R1 Rcm | 8.5 | $29M | 3.0M | 9.67 | |
| Zogenix | 8.0 | $27M | 495k | 55.01 | |
| Danaher Corporation (DHR) | 6.2 | $21M | 159k | 132.18 | |
| NuVasive | 5.5 | $19M | 331k | 56.79 | |
| Sanofi-Aventis SA (SNY) | 4.3 | $15M | 332k | 44.28 | |
| Radius Health | 3.8 | $13M | 645k | 19.94 | |
| eHealth (EHTH) | 3.7 | $13M | 201k | 62.34 | |
| Ascendis Pharma A S (ASND) | 3.6 | $12M | 103k | 117.70 | |
| Sarepta Therapeutics (SRPT) | 2.9 | $10M | 84k | 119.19 | |
| Ensign (ENSG) | 2.4 | $8.2M | 160k | 51.23 | |
| Abiomed | 2.3 | $7.8M | 27k | 285.60 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.1 | $7.0M | 38k | 183.94 | |
| Fate Therapeutics (FATE) | 1.8 | $6.1M | 350k | 17.57 | |
| Tg Therapeutics (TGTX) | 1.8 | $6.0M | 749k | 8.04 | |
| Deciphera Pharmaceuticals | 1.7 | $5.8M | 250k | 23.21 | |
| Aerie Pharmaceuticals | 1.6 | $5.5M | 115k | 47.50 | |
| Array BioPharma | 1.5 | $5.2M | 214k | 24.38 | |
| Argenx Se (ARGX) | 1.4 | $4.9M | 39k | 124.83 | |
| Ptc Therapeutics I (PTCT) | 1.1 | $3.8M | 101k | 37.64 | |
| Arena Pharmaceuticals | 1.0 | $3.4M | 76k | 44.84 | |
| BioCryst Pharmaceuticals (BCRX) | 1.0 | $3.4M | 413k | 8.14 | |
| ArQule | 0.9 | $3.1M | 647k | 4.79 | |
| Teligent | 0.9 | $3.0M | 2.6M | 1.16 | |
| Ironwood Pharmaceuticals (IRWD) | 0.8 | $2.6M | 196k | 13.53 | |
| Dermira | 0.7 | $2.4M | 180k | 13.55 | |
| Xenon Pharmaceuticals (XENE) | 0.7 | $2.3M | 224k | 10.16 | |
| Medicines Company | 0.6 | $2.1M | 76k | 27.95 | |
| Apellis Pharmaceuticals (APLS) | 0.6 | $2.0M | 104k | 19.50 | |
| Tricida | 0.6 | $1.9M | 50k | 38.62 | |
| Myokardia | 0.5 | $1.8M | 35k | 51.98 | |
| Coherus Biosciences (CHRS) | 0.5 | $1.6M | 120k | 13.64 | |
| Crispr Therapeutics (CRSP) | 0.5 | $1.5M | 42k | 35.73 | |
| Cymabay Therapeutics | 0.4 | $1.4M | 107k | 13.28 | |
| Affimed Therapeutics B V | 0.4 | $1.4M | 322k | 4.20 | |
| Centene Corporation (CNC) | 0.4 | $1.3M | 24k | 53.09 | |
| Foamix Pharmaceuticals | 0.3 | $1.1M | 295k | 3.75 | |
| Caretrust Reit (CTRE) | 0.3 | $977k | 41k | 23.68 | |
| Eiger Biopharmaceuticals | 0.3 | $975k | 70k | 13.99 | |
| Intercept Pharmaceuticals In | 0.2 | $800k | 438.00 | 1826.48 | |
| Invacare Corporation | 0.2 | $662k | 79k | 8.37 | |
| Dicerna Pharmaceuticals | 0.2 | $602k | 41k | 14.66 | |
| Heska Corporation | 0.2 | $569k | 6.7k | 85.18 | |
| Concert Pharmaceuticals I equity | 0.2 | $569k | 47k | 12.07 | |
| Albireo Pharma | 0.2 | $581k | 18k | 32.23 | |
| Otonomy | 0.1 | $474k | 180k | 2.63 | |
| Pfenex | 0.1 | $468k | 76k | 6.18 | |
| BioScrip | 0.1 | $246k | 123k | 2.00 | |
| Aquinox Pharmaceuticals | 0.1 | $199k | 74k | 2.70 | |
| Illumina (ILMN) | 0.0 | $126k | 405.00 | 311.11 | |
| Novavax Inc Cmn Stock cmn | 0.0 | $77k | 1.5k | 53.07 | |
| Celgene Corp right 12/31/2011 | 0.0 | $7.0k | 6.0k | 1.17 | |
| Concert Pharmaceuticals Inc call | 0.0 | $2.0k | 23.00 | 86.96 |
